Try our Advanced Search for more refined results
Bristol-Myers Squibb Co. et al v. AstraZeneca Pharmaceuticals LP et al
Case Number:
1:23-cv-00459
Court:
Nature of Suit:
Judge:
Firms
Companies
- AstraZeneca PLC
- Bristol-Myers Squibb Co.
- Dana-Farber Cancer Institute Inc.
- Ono Pharmaceutical Co. Ltd
Sectors & Industries:
-
August 01, 2023
AstraZeneca Sets Aside $510M For Bristol-Myers Patent Deal
AstraZeneca has set aside $510 million to resolve Bristol-Myers Squibb Co.'s litigation that it infringed cancer treatment patents to create rival immunotherapy drugs, according to a recent securities filing.
-
July 31, 2023
Bristol-Myers, AstraZeneca Agree To End Drug Patent Fight
A Delaware federal judge on Monday dismissed Bristol-Myers Squibb Co.'s litigation accusing AstraZeneca of infringing cancer treatment patents to create a rival immunotherapy drug, after the pharmaceutical giants reached an agreement.